(Q38434618)

3 September 2017

title

Adherence with migraine prophylaxis in clinical practice (English)

1 reference

3 September 2017

1 reference

Ariel Berger

1

1 reference

3 September 2017

Lisa M Bloudek

series ordinal

2

1 reference

3 September 2017

Sepideh F Varon

series ordinal

3

1 reference

3 September 2017

Gerry Oster

series ordinal

4

1 reference

3 September 2017

publication date

2 February 2012

1 reference

3 September 2017

1 reference

3 September 2017

volume

12

1 reference

3 September 2017

issue

7

1 reference

3 September 2017

page(s)

541-549

1 reference

Migraine prevalence, disease burden, and the need for preventive therapy

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

Costs associated with outpatient, emergency room and inpatient care for migraine in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

Health care utilization in patients with migraine: demographics and patterns of care in the ambulatory setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

Chronic migraine: comorbidities, risk factors, and rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

Clinical features, pathophysiology, and treatment of medication-overuse headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

Tricyclic antidepressants and headaches: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

Topiramate in migraine prevention: results of a large controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

Migraine diagnosis and treatment: results from the American Migraine Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

Chronic migraine: epidemiology and disease burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

Topiramate in migraine prophylaxis: long-term impact on resource utilization and cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

The medical care utilization and costs associated with migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

Good and poor adherence: optimal cut-point for adherence measures using administrative claims data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

The impact of proton pump inhibitor compliance on health-care resource utilization and costs in patients with gastroesophageal reflux disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

Antidepressant adherence after psychiatric hospitalization among VA patients with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

Persistence with once-daily versus twice-daily bupropion for the treatment of depression in a large managed-care population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

Once-daily bupropion associated with improved patient adherence compared with twice-daily bupropion in treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

Differences in compliance patterns across the selective serotonin reuptake inhibitors (SSRIs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00530.X

10.1111/J.1533-2500.2012.00530.X

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference